Materials Science seminar by Chun Li, PhD, Cancer Systems Imaging, Univ. of TX MD Anderson Cancer Ctr.

The development of biocompatible nanoparticles for molecular imaging and targeted cancer therapy is an area of considerable current interest across a number of disciplines. The premise is that nanoparticles possess unique structural and functional properties that are not available from either small-molecular-weight molecules or bulk materials.